GlassScriptPhysician profile
Hassan Ahmad
NPI 1851772057
$2,732.91
in general payments reported to CMS, 2019-2025
8 companies · $527 in 2025
The $527 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $135 · 2022: $118 · 2023: $646 · 2024: $1,308 · 2025: $527.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,833 · Food and Beverage: $647.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,833.18 |
| Food and Beverage | $647.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,081.66 | 2024 | |
| Avita Medical Americas, LLC | $645.67 | 2023 | Recell |
| Davol INC. | $537.09 | 2024-2025 | Phasix Mesh |
| Zimmer Biomet Holdings, INC. | $168.26 | 2024-2025 | Advantagerib, Ribfix Titan |
| Astrazeneca Pharmaceuticals LP | $134.78 | 2019 | |
| Smith+Nephew, INC. | $117.62 | 2022 | |
| Polynovo North America LLC | $33.26 | 2025 | Novosorb Btm |
| Ethicon US, LLC | $14.57 | 2025 | Echelon; Endopath, Echelon Endopath, Echelon Circular |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hassan Ahmad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.